TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for.

Slides:

Advertisements

Similar presentations

4 th Cutaneous Lymphoma Patient Educational Forum Saturday April 14, 2012 Cummings Auditorium Women's College Hospital.

Advertisements

Mycosis Fungoides and Sezary Syndrome

By the end of this session you should know:

NOT ALL SWELLING WITH REDNESS AND BAD SMELLY DISACHRGE IS NECESSARLY AN ABSCESS Al-Sharabati, Mohamed Barakat, MD, Pathologist Rasheed, Osaid, RN, CNS.

Melanoma of the Skin Regional lymph nodes for skin sites of the head and neck. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd.

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.

T Cell Low Grade Lymphomas. General Principles General Principles  Usually Primary Skin lymphomas  Typically indolent Course  Conservative management.

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma by Joshua Richter, Natalia Neparidze,

Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan.

Critical Reviews in Oncology / Hematology

The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry Moritz.

The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.

The beauty of TLR agonists for CTCL

Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses by Alain H. Rook, Gary S. Wood, Elisa K. Yoo,

Elevated Serum CD44 Level Is Associated With Unfavorable Outcome in Non-Hodgkin's Lymphoma by Raija Ristamäki, Heikki Joensuu, Kimmo Lappalainen, Lasse.

MBL: mostly benign lymphocytes, but…

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Tax fingerprint in adult T-cell leukemia

How I treat elderly patients with myeloma

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells by Lucie Heinzerling,

Nonmyeloablative conditioning for relapsed follicular lymphoma

Superior Survival after Autologous vs

Practical Management of CD30+ Lymphoproliferative Disorders

by Juliette J. Hoefnagel, Remco Dijkman, Katia Basso, Patty M

T-cell NHL: US Perspective

Solitary plasmacytoma of bone and asymptomatic multiple myeloma

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

When and which aggressive treatment ? CHEMOTHERAPY IN CTCL

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index by Chor-Sang Chim, Shing-Yan.

Latest lymphoma classification is skin deep

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience by Daryl Tan, Sandra.

Lymphoma spread? Target CD47-SIRPα!

WHO-EORTC classification for cutaneous lymphomas

Jonathan E. Blume, MD, Howard L. Stoll, MD, Richard T. Cheney, MD

The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry Moritz.

by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros

Fluorescence In Situ Hybridization

Peripheral T Cell Lymphoma Prognostic Factors

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report by Richard L.

M. J. Röβler, G. Rappl, M. Muche, D. O. Hasselmann, W. Sterry, W

Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

The applicability and prognostic value of the TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome.

Radiation Therapy for Cutaneous T-Cell Lymphomas

Treatment of 7 patients with relapsed/refractory NK/T-cell lymphomas treated with pembrolizumab. Treatment of 7 patients with relapsed/refractory NK/T-cell.

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma by Pier Luigi Zinzani, Vincent.

Liisa Väkevä, Annamari Ranki Journal of Investigative Dermatology

Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet.

Keith M. Sullivan, Paolo Muraro, Alan Tyndall

Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome

Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma Sean Whittaker Journal of.

Lymphoma Associated With Human Immunodeficiency Virus Infection

T Cell Receptor-γ Gene Analysis of CD30+ Large Atypical Individual Cells in CD30+ Large Primary Cutaneous T Cell Lymphomas Sylke Gellrich, Anke Wilks,

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome Peggy A. Wu,

Changes throughout time in the lineage content of clones regenerated in secondary mice. Changes throughout time in the lineage content of clones regenerated.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase by Yok-Lam Kwong, Thomas S. Y.

CD4/CD8 double-negative early-stage mycosis fungoides associated with primary cutaneous follicular center lymphoma Jeong Hee Cho-Vega, MD, PhD, Jaime.

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients by Marcel W. Bekkenk, Maarten.

IL32 is highly expressed in mycosis fungoides lesional skin.

CR-rate ratios with 95% CIs

Hepatosplenic T-Cell Lymphoma: Clinicopathological Features and Treatment Outcomes: Report From The North American Peripheral T-Cell Lymphoma Consortium.

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL)

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.

by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal

Is Skull-Base to Proximal Thigh PET/CT Enough

Outcomes in patients with PTCL

Presentation transcript:

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)‏ by Youn H. Kim, Rein Willemze, Nicola Pimpinelli, Sean Whittaker, Elise A. Olsen, Annamari Ranki, Reinhard Dummer, and Richard T. Hoppe Blood Volume 110(2):479-484 July 15, 2007 ©2007 by American Society of Hematology

Body regions as defined in the proposed TNM system for the designation of T (skin involvement) category. Body regions as defined in the proposed TNM system for the designation of T (skin involvement) category. Left and right extremities are assessed as separate body regions. The designation of these body regions are based on regional LN drainage patterns. Youn H. Kim et al. Blood 2007;110:479-484 ©2007 by American Society of Hematology

Clinical examples of proposed T1 (discrete solitary lesion) category of primary cutaneous lymphomas. Clinical examples of proposed T1 (discrete solitary lesion) category of primary cutaneous lymphomas. (A) T1a (solitary lesion equal or less than 5 cm), CD30 + anaplastic large cell lymphoma. (B) T1b (solitary lesion greater than 5 cm), NK/T-cell, nasal-type, lymphoma. Youn H. Kim et al. Blood 2007;110:479-484 ©2007 by American Society of Hematology

Clinical examples of proposed T2a (regional involvement with lesions within a 15 cm diameter area) category of primary cutaneous lymphomas. Clinical examples of proposed T2a (regional involvement with lesions within a 15 cm diameter area) category of primary cutaneous lymphomas. (A) CD30 + anaplastic large cell lymphoma. (B) Follicle center lymphoma. (C) Diffuse large B-cell lymphoma, leg-type. Youn H. Kim et al. Blood 2007;110:479-484 ©2007 by American Society of Hematology

Clinical examples of proposed T2b (regional involvement with lesions in an area between 15 cm and 30 cm diameter) category of primary cutaneous lymphomas. Clinical examples of proposed T2b (regional involvement with lesions in an area between 15 cm and 30 cm diameter) category of primary cutaneous lymphomas. (A) diffuse large B-cell lymphoma, leg-type. (B) Follicle center lymphoma. (C) Follicle center lymphoma. Youn H. Kim et al. Blood 2007;110:479-484 ©2007 by American Society of Hematology

Clinical examples of proposed T2c (regional involvement with lesions more than 30 cm in diameter) category of cutaneous lymphomas. Clinical examples of proposed T2c (regional involvement with lesions more than 30 cm in diameter) category of cutaneous lymphomas. (A) Diffuse large B-cell lymphoma, leg-type. (B) Follicle center lymphoma. (C) Diffuse large B-cell lymphoma, leg-type. Youn H. Kim et al. Blood 2007;110:479-484 ©2007 by American Society of Hematology

Clinical examples of proposed T3 (generalized) category of cutaneous lymphomas. Clinical examples of proposed T3 (generalized) category of cutaneous lymphomas. (A) T3a (multiple lesions involving 2 noncontiguous body regions), follicle center lymphoma. (B) T3b (multiple lesions involving 3 or more body regions), CD30 + anaplastic large-cell lymphoma. Youn H. Kim et al. Blood 2007;110:479-484 ©2007 by American Society of Hematology